EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 397 filers reported holding EXELIXIS INC in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,699,814 | +53.0% | 489,694 | +33.8% | 0.21% | +49.3% |
| Q2 2023 | $6,994,451 | +140.8% | 366,010 | +144.6% | 0.14% | +133.9% |
| Q1 2023 | $2,904,551 | -58.3% | 149,642 | -65.5% | 0.06% | -55.3% |
| Q4 2022 | $6,962,643 | -33.9% | 434,080 | -35.4% | 0.13% | -52.5% |
| Q3 2022 | $10,534,000 | +1847.1% | 671,789 | +2168.7% | 0.28% | +796.8% |
| Q4 2021 | $541,000 | -60.6% | 29,611 | -54.4% | 0.03% | -68.0% |
| Q3 2021 | $1,372,000 | +6.6% | 64,908 | -8.1% | 0.10% | -37.8% |
| Q2 2021 | $1,287,000 | +36.9% | 70,615 | +69.7% | 0.16% | +13.9% |
| Q1 2021 | $940,000 | +4.3% | 41,600 | -7.3% | 0.14% | -6.2% |
| Q4 2020 | $901,000 | +146.2% | 44,876 | +111.2% | 0.15% | 0.0% |
| Q1 2020 | $366,000 | +75.1% | 21,247 | +79.4% | 0.15% | +139.3% |
| Q4 2019 | $209,000 | – | 11,841 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $199,507,000 | 56.91% |
| Sargent Investment Group, LLC | 1,032,560 | $18,193,000 | 3.40% |
| Bellevue Group AG | 3,930,700 | $69,259,000 | 1.10% |
| CAPITAL MANAGEMENT CORP /VA | 231,880 | $4,086,000 | 1.04% |
| Orbimed Advisors | 3,753,700 | $66,140,000 | 0.94% |
| TEALWOOD ASSET MANAGEMENT INC | 121,848 | $2,147,000 | 0.90% |
| FARALLON CAPITAL MANAGEMENT LLC | 7,500,000 | $132,150,000 | 0.89% |
| Chicago Capital, LLC | 806,113 | $14,204,000 | 0.87% |
| Penn Capital Management Company, LLC | 456,587 | $8,045,000 | 0.84% |
| AJO, LP | 7,636,882 | $134,561,000 | 0.80% |